Friday, April 04, 2025
Additionally, to position India as a global leader in healthcare in line with Vishwaguru philosophy, we urge the government to introduce tax incentives for healthcare services exports and provide robust support for R&D in innovative healthcare services. This will not only benefit millions of patients but also boost India’s stature in the global healthcare ecosystem
"As the government prepares for the 2025 Budget, we hope for a significant increase in funding to expand dialysis services under the PMNDP, addressing the urgent need for dialysis care across the country. Only 15% of patients who require dialysis get access currently. With Lakhs of new patients requiring regular dialysis, increasing dialysis care outlay and thereby increasing access to life sustaining care is crucial.
Additionally, to position India as a global leader in healthcare in line with Vishwaguru philosophy, we urge the government to introduce tax incentives for healthcare services exports and provide robust support for R&D in innovative healthcare services. This will not only benefit millions of patients but also boost India’s stature in the global healthcare ecosystem" - Vikram Vuppala Founder and CEO, NephroPlus
About Vikram Vuppala Founder and CEO, NephroPlus (https://nephroplus.com/)
Vikram Vuppala is the Founder & CEO of India’s largest dialysis network - NephroPlus. After spending 10 years in the US healthcare industry, his passion for redefining healthcare delivery in India prompted him to launch NephroPlus in 2010. Today, NephroPlus has expanded to 400+ dialysis clinics in more than 230+ cities across 4 countries. It has rapidly grown under Vikram’s leadership to become the Asia's leading dialysis network.
He had raised a Series A Private equity investment of $4.3 MM from Bessemer Venture Partners (BVP) in Nov 2011, a Series B investment of $10 MM in May 2014 from IFC (World Bank arm) and BVP, and a Series C investment of $15 MM in Aug 2016 from IFC and SeaLink Capital. And recently, NephroPlus has secured INR 860 Crores in the Series F round, from Quadria Capital, a Singapore based healthcare-focused private equity firm.
Prior to founding NephroPlus, Vikram was a strategy consultant at McKinsey in the US. Vikram with over 18 years of global healthcare experience has helped hospitals, chains of clinics, healthcare distributors, and pharmaceutical clients on various strategic issues such as business development, growth strategy, portfolio rationalisation, and M&A. He has been a speaker at numerous entrepreneurial, healthcare and investment conferences. Vikram did his B. Tech. from IIT-Kharagpur and a full-time MBA from Chicago Booth
.jpeg)
.jpeg)
.jpeg)
.jpg)